Autologous Fat Grafting in the Treatment of Facial Scleroderma

Table 2

Baseline demographic, clinical, and therapeutic characteristics of patients.

Case	Age/sex	Disease duration (year)	Systemic sclerosis type	Liposuction area	Injected fat volume (ml)
1	41/f	8	limited	trochanteric	40
2	54/f	9	diffuse	Buttock	20
3	31/f	5	diffuse	flank	15
4	38/f	6	limited	periumbilical	30
5	37/f	7	diffuse	Buttock	20
6	32/f	5	diffuse	periumbilical	30
7	51/f	8	limited	trochanteric	25
8	49/f	10	limited	periumbilical	30
9	31/f	5	diffuse	trochanteric	20
10	34/f	8	diffuse	trochanteric	30
11	52/f	6	diffuse	Buttock	35
12	34/f	4	limited	trochanteric	40
13	29/f	5	diffuse	trochanteric	25
14	43/f	4	limited	periumbilical	30
15	39/f	7	diffuse	Buttock	15
16	32/f	7	diffuse	Buttock	30